Smooth Muscle Cell–Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging

No abstract is available for this paper.

• Publication year

  2018

• Venue

  HYPERTENSION

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.117.10437PMID 29463624PMCID PMC5843545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Essential role of ICAM-1 in aldosterone-induced atherosclerosis.

  2017cited by this paper
• 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor null mice: informing cell-type-specific roles.

  2017cited by this paper
• Endothelial mineralocorticoid receptor contributes to systolic dysfunction induced by pressure overload without modulating cardiac hypertrophy or inflammation

  2017cited by this paper
• Vascular Smooth Muscle Mineralocorticoid Receptor Contributes to Coronary and Left Ventricular Dysfunction After Myocardial Infarction

  2016cited by this paper
• Age-Associated Changes in the Vascular Renin-Angiotensin System in Mice

  2016cited by this paper
• Vascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications

  2016cited by this paper
• Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging.

  2016cited by this paper
• Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females.

  2016cited by this paper
• Effects of Testosterone Treatment in Older Men.

  2016cited by this paper
• Cellular mechanisms of MR regulation of adipose tissue physiology and pathophysiology.

  2015cited by this paper
• Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet–Induced Arterial Stiffening in Female Mice

  2015cited by this paper
• Effect of vitamin K on vascular health and physical function in older people with vascular disease–a randomised controlled trial

  2015cited by this paper
• Aging impairs smooth muscle-mediated regulation of aortic stiffness: a defect in shock absorption function?

  2014cited by this paper
• Age-related vascular gene expression profiling in mice.

  2014cited by this paper
• Smooth Muscle Cell Mineralocorticoid Receptors Are Mandatory for Aldosterone–Salt to Induce Vascular Stiffness

  2014cited by this paper
• Sex hormones in the cardiovascular system

  2014cited by this paper
• Aldosterone Promotes Vascular Remodeling by Direct Effects on Smooth Muscle Cell Mineralocorticoid Receptors

  2014cited by this paper
• Endothelial Sodium Channels Trigger Endothelial Salt Sensitivity With Aging

  2014cited by this paper
• Serum carboxy-terminal telopeptide of type I collagen (ICTP) as a surrogate marker for vulnerable plaques in atherosclerotic patients: a pilot study.

  2013cited by this paper
• Age-associated pro-inflammatory adaptations of the mouse thoracic aorta

  2013cited by this paper
• Role of Rac1–mineralocorticoid-receptor signalling in renal and cardiac disease

  2013cited by this paper
• Aldosterone Increases Early Atherosclerosis and Promotes Plaque Inflammation Through a Placental Growth Factor‐Dependent Mechanism

  2013cited by this paper
• Role of mineralocorticoid receptors in arterial stiffness in human aging.

  2013cited by this paper
• Long‐term application of the aldosterone antagonist spironolactone prevents stiff endothelial cell syndrome

  2013cited by this paper
• Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation.

  2012cited by this paper
• Mitochondria and cardiovascular aging.

  2012cited by this paper
• Direct Regulation of Blood Pressure by Smooth Muscle Cell Mineralocorticoid Receptors

  2012cited by this paper
• Age as a risk factor.

  2012cited by this paper
• Aortic stiffness, blood pressure progression, and incident hypertension.

  2012cited by this paper
• Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease

  2012cited by this paper
• Arterial stiffness/elasticity in the contribution to progression of heart failure.

  2012cited by this paper
• Supplementary Materials for Age-Related Intimal Stiffening Enhances Endothelial Permeability and Leukocyte Transmigration

  2011cited by this paper
• Aldosterone Regulates Vascular Gene Transcription via Oxidative Stress–Dependent and –Independent Pathways

  2011cited by this paper
• Elevated Mineralocorticoid Receptor Activity in Aged Rat Vascular Smooth Muscle Cells Promotes a Proinflammatory Phenotype via Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase and Epidermal Growth Factor Receptor–Dependent Pathways

  2010cited by this paper
• Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice.

  2010cited by this paper
• Mechanisms of vascular aging: new perspectives.

  2010cited by this paper
• Circulating Biomarkers of Collagen Metabolism in Cardiac Diseases

  2010cited by this paper
• Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study

  2010cited by this paper
• Arterial aging and subclinical arterial disease are fundamentally intertwined at macroscopic and molecular levels.

  2009cited by this paper
• Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism

  2008cited by this paper
• Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients

  2008cited by this paper
• Aldosterone and amiloride alter ENaC abundance in vascular endothelium

  2008cited by this paper
• Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation

  2008cited by this paper
• Mineralocorticoid Receptor Activation Promotes Vascular Cell Calcification

  2007cited by this paper
• Role of the renin–angiotensin–aldosterone system in vascular remodeling and inflammation: a clinical review

  2006cited by this paper
• Collagen type-I degradation is related to arterial stiffness in hypertensive and normotensive subjects

  2006cited by this paper
• Regulation of Blood Flow in the Microcirculation

  2005cited by this paper
• Angiotensin II and Aldosterone Regulate Gene Transcription Via Functional Mineralocortocoid Receptors in Human Coronary Artery Smooth Muscle Cells

  2005cited by this paper
• Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension.

  2005cited by this paper
• Hypertension and Left Ventricular Hypertrophy : The 4 E Effects of Eplerenone , Enalapril , and Eplerenone / Enalapril in Patients With Essential

  2003cited by this paper
• Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease.

  2003cited by this paper
• Epithelial sodium channel and the control of sodium balance: interaction between genetic and environmental factors.

  2002cited by this paper
• Selective aldosterone blockade prevents angiotensin II/salt-induced vascular inflammation in the rat heart.

  2002cited by this paper
• Exercise capacity and mortality among men referred for exercise testing.

  2002cited by this paper
• Prevention of aortic and cardiac fibrosis by spironolactone in old normotensive rats.

  2001cited by this paper
• Mineralocorticoid Receptor Affects AP-1 and Nuclear Factor-&kgr;B Activation in Angiotensin II–Induced Cardiac Injury

  2001cited by this paper
• Limiting factors for maximum oxygen uptake and determinants of endurance performance.

  2000cited by this paper
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

  2000cited by this paper
• The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

  1999cited by this paper
• Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats.

  1997cited by this paper

• Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney disease

  2025cites this paper
• Elucidating emerging signaling pathways driving endothelial dysfunction in cardiovascular aging.

  2025cites this paper
• Long-Term Time in Target Range for Systolic Blood Pressure Since Childhood and Midlife Arterial Stiffness

  2025cites this paper
• The angiotensin II type 2 receptor attenuates aging-associated arterial stiffness in female mice.

  2025cites this paper
• Impact of Blood Pressure Across the Life Course on Arterial Stiffness in Midlife: The Mediating Role of Metabolic Factors

  2025cites this paper
• Mineralocorticoid and estrogen receptors as sex-dependent modulators of vascular health in aging and obesity.

  2025cites this paper
• Diabetes-Related Changes in Carotid Wall Properties: Role of Triglycerides

  2024cites this paper
• Mineralocorticoid receptor promotes cardiac macrophage inflammaging

  2024cites this paper
• Microvascular angiotensin II type 2 receptor function is enhanced in young females and declines in a model of murine aging

  2024cites this paper
• Attenuation of Hypertension and protection of vascular inflammation in hyperaldosteronism: GPER1 as potential therapeutic candidate when MR antagonist is less satisfying?

  2024cites this paper
• Resistant Hypertension: A Brief Review of Pathophysiology

  2024cites this paper
• Mineralocorticoid Receptors in Vascular Smooth Muscle: Blood Pressure and Beyond

  2024influential citation
• Aging of the Arterial System

  2023cites this paper
• Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists

  2023cites this paper
• Inhibition of the Histone Methyltransferase EZH2 Induces Vascular Stiffness.

  2023cites this paper
• Extra-adrenal aldosterone: a mini review focusing on the physiology and pathophysiology of intrarenal aldosterone

  2023cites this paper
• The Mineralocorticoid Receptor in the Vasculature: Friend or Foe?

  2023cites this paper
• Primary hyperaldosteronism in Acute Central Serous Chorioretinopathy: a real need for screening?

  2023cites this paper
• Cardiovascular aging: from cellular and molecular changes to therapeutic interventions

  2023cites this paper
• Smooth Muscle Mineralocorticoid Receptor Promotes Hypertension After Preeclampsia

  2023cites this paper
• Themed Issue: Emerging Fields for Therapeutic Targeting of the Aldosterone-Mineralocorticoid Receptor Signaling Pathway

  2022cites this paper
• Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases.

  2022cites this paper
• Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms.

  2022cites this paper
• Multi-omic analysis of the cardiac cellulome defines a vascular contribution to cardiac diastolic dysfunction in obese female mice

  2022cites this paper
• Benefits of Surgical Over Medical Treatment for Unilateral Primary Aldosteronism

  2022cites this paper
• Progressive aortic stiffness in aging C57Bl/6 mice displays altered contractile behaviour and extracellular matrix changes

  2022cites this paper
• Primary Aldosteronism: State-of-the-Art Review.

  2022cites this paper
• The Diabetic Cardiorenal Nexus

  2022cites this paper
• Engineering Smooth Muscle to Understand Extracellular Matrix Remodeling and Vascular Disease

  2022cites this paper
• Causes, Evaluation, and Treatment of Secondary and Resistant Hypertension

  2022cites this paper
• Smooth muscle mineralocorticoid receptor as an epigenetic regulator of vascular aging.

  2022cites this paper
• Mechanism by Which Inflammation and Oxidative Stress Induce Mineralocorticoid Receptor Gene Expression in Aging Vascular Smooth Muscle Cells

  2022cites this paper
• Importance of Micromilieu for Pathophysiologic Mineralocorticoid Receptor Activity—When the Mineralocorticoid Receptor Resides in the Wrong Neighborhood

  2022cites this paper
• [New clinical opportunities for mineralocorticoid receptor antagonists: focus on antifibrotic effects].

  2021cites this paper
• Mineralocorticoid Receptor in Smooth Muscle Contributes to Pressure Overload-Induced Heart Failure.

  2021cites this paper
• Kidney and epigenetic mechanisms of salt-sensitive hypertension

  2021cites this paper
• Mineralocorticoid receptor antagonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease.

  2021cites this paper
• Eplerenone Improves Pulmonary Vascular Remodeling and Hypertension by Inhibition of the Mineralocorticoid Receptor in Endothelial Cells

  2021cites this paper
• Mineralocorticoid receptor blockade normalizes coronary resistance in obese swine independent of functional alterations in Kv channels

  2021cites this paper
• Posttranslational Modifications of the Mineralocorticoid Receptor and Cardiovascular Aging

  2021cites this paper
• Vascular cell-specific roles of mineralocorticoid receptors in pulmonary hypertension

  2021cites this paper
• MLK3 mediates impact of PKG1α on cardiac function and controls blood pressure through separate mechanisms

  2021cites this paper
• Sex Differences in Molecular Mechanisms of Cardiovascular Aging

  2021cites this paper
• Sex differences in the time course and mechanisms of vascular and cardiac aging in mice: role of the smooth muscle cell mineralocorticoid receptor.

  2020cites this paper
• Vascular and inflammatory mineralocorticoid receptors in kidney disease

  2020cites this paper
• Adrenal stress hormone action in skeletal muscle during exercise training: An old dog with new tricks?

  2020cites this paper
• Effect of spironolactone on cardiovascular morbidity and mortality in patients with hypertension and glucose metabolism disorders (ESCAM): a study protocol for a pragmatic randomised controlled trial

  2020cites this paper
• Mineralocorticoid Receptor and Endothelial Dysfunction in Hypertension

  2019cites this paper
• Role of Aldosterone and Mineralocorticoid Receptor in Cardiovascular Aging

  2019cites this paper
• Mineralocorticoid antagonists in the treatment of central serous chorioetinopathy: Review of the pre-clinical and clinical evidence.

  2019cites this paper
• PKC-delta mediates mineralocorticoid receptor activation by angiotensin II to modulate smooth muscle cell function.

  2019cites this paper
• Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment

  2019cites this paper
• The Endothelial Mineralocorticoid Receptor: Contributions to Sex Differences in Cardiovascular Disease.

  2019cites this paper
• Vascular smooth muscle cell senescence and age-related diseases: State of the art.

  2019cites this paper
• Sex differences in mechanisms of arterial stiffness

  2019influential citation
• MR (Mineralocorticoid Receptor) Induces Adipose Tissue Senescence and Mitochondrial Dysfunction Leading to Vascular Dysfunction in Obesity

  2019cites this paper
• Healthy aging: A bibliometric analysis of the literature.

  2019cites this paper
• Molecular Mechanisms of Primary Aldosteronism

  2019cites this paper
• Primary Aldosteronism Diagnosis and Management: A Clinical Approach.

  2019cites this paper
• Vascular mineralocorticoid receptor activation and disease.

  2019cites this paper
• Potential Role of Antihypertensive Medications in Preventing Excessive Arterial Stiffening

  2018cites this paper
• No Significant Role for Smooth Muscle Cell Mineralocorticoid Receptors in Atherosclerosis in the Apolipoprotein-E Knockout Mouse Model

  2018cites this paper
• Vascular Mineralocorticoid Receptor: Evolutionary Mediator of Wound Healing Turned Harmful by Our Modern Lifestyle

  2018cites this paper
• The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

  2018cites this paper
• Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness

  2018cites this paper
• Epithelial Sodium Channel in Aldosterone-Induced Endothelium Stiffness and Aortic Dysfunction

  2018cites this paper
• THE IMPACT OF EXOGENOUS AND ENDOGENOUS FACTORS ON VASCULAR WALL ELASTICITY AND POTENTIAL CLINICAL EFFECTS

  year unknowncites this paper